COMMUNIQUÉS West-GlobeNewswire

-
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
29/08/2025 -
Alliance Recovery Expands in Orange County, California, Improving Access to Affordable Addiction Treatment
29/08/2025 -
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
29/08/2025 -
Ultragenyx to Participate at Investor Conferences in September
29/08/2025 -
Information on the total number of voting rights and shares
29/08/2025 -
Informations sur le nombre total de droits de vote et d'actions
29/08/2025 -
Empower Dental Upland Announces Grand Opening, Bringing Advanced Dental Care and Compassionate Services to the Upland Community
29/08/2025 -
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/08/2025 -
KFSHRC Sets Global Benchmark in Robotic Surgery, Expanding World-First Innovations
29/08/2025 -
Outliyr Releases Biological Age Testing Case Study Revealing 13.1-Year Variation Across Seven Products
29/08/2025 -
Biohacker Direct Expands Wellness Portfolio with FDA-Registered Hyperbaric Chambers
29/08/2025 -
Renaissance Recovery California Expands to Serve 16 Additional Patients, Meeting Growing Demand for Addiction and Mental Health Treatment
29/08/2025 -
ALX Oncology to Participate in Upcoming Investor Conferences in September
29/08/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2025
29/08/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 34 - 2025
29/08/2025 -
Évolutions au sein du Comité exécutif
29/08/2025 -
LTC ACO Ranks Top 3 Nationally in Savings Per Beneficiary While Advancing Quality in 2024
29/08/2025 -
HealthEquity's AI-Powered Tool Recognized for Innovation in Streamlining Benefits Education
29/08/2025 -
Legend Senior Living® Acquires Two New Residences, Expands Into Missouri
29/08/2025
Pages